GAMMA Investing LLC Grows Stock Position in Sotera Health Company (NASDAQ:SHC)

GAMMA Investing LLC boosted its holdings in Sotera Health Company (NASDAQ:SHC) by 816.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,650 shares of the company’s stock after acquiring an additional 33,541 shares during the quarter. GAMMA Investing LLC’s holdings in Sotera Health were worth $439,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the business. Quarry LP acquired a new stake in Sotera Health in the fourth quarter valued at $28,000. Blue Trust Inc. boosted its stake in shares of Sotera Health by 504.0% during the fourth quarter. Blue Trust Inc. now owns 4,192 shares of the company’s stock valued at $57,000 after acquiring an additional 3,498 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of Sotera Health by 37.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after acquiring an additional 1,640 shares during the last quarter. Sterling Capital Management LLC boosted its stake in shares of Sotera Health by 58.5% during the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company’s stock valued at $124,000 after acquiring an additional 3,331 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Sotera Health by 39.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company’s stock valued at $127,000 after acquiring an additional 2,627 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SHC. The Goldman Sachs Group upgraded Sotera Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. Barclays reduced their target price on Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, April 10th. Wall Street Zen downgraded Sotera Health from a “buy” rating to a “hold” rating in a report on Saturday, June 7th. Finally, Piper Sandler cut their price objective on Sotera Health from $15.00 to $13.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, Sotera Health currently has an average rating of “Moderate Buy” and an average price target of $15.80.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $10.94 on Friday. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The business has a 50 day moving average price of $11.91 and a two-hundred day moving average price of $12.46. The company has a quick ratio of 2.19, a current ratio of 2.46 and a debt-to-equity ratio of 5.55. The firm has a market cap of $3.11 billion, a PE ratio of 136.77 and a beta of 1.87.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.02. The firm had revenue of $254.52 million during the quarter, compared to analyst estimates of $245.56 million. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. Sotera Health’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.13 EPS. Sell-side analysts expect that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.